tiprankstipranks
TheraCryf Expands Equity with New Share Issue
Company Announcements

TheraCryf Expands Equity with New Share Issue

Evgen Pharma (GB:TCF) has released an update.

Don't Miss Our Christmas Offers:

TheraCryf plc, a UK-based clinical stage drug development company specializing in oncology and neuropsychiatry, has issued over 2.27 million new ordinary shares to cover professional fees. This move brings the company’s total shares in issue to 429.6 million, offering potential investors an opportunity to engage with its promising pipeline of treatments. TheraCryf is listed on AIM in London under the ticker TCF.

For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskTheraCryf Expands Pipeline with Chronos Acquisition
TipRanks UK Auto-Generated NewsdeskTheraCryf Secures European Patent for Ox-1 Antagonist
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App